Journal club on “Increasing evidence for the safety of fovea-involving half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy & Treat-and-extend dosing of intravitreal anti-VEGF agents in neovascular age-related macular degeneration: a meta-analysis”